Level and Factors Associated with Participation in Population-Based Cancer Screening in Safranbolu District of Karabuk, Turkey
Background: Cervix, breast and colorectal cancers are included in the national population-based screening (PBS) program in Turkey. This study aimed to assess participation in PBSs for these cancers and to identify factors associated with participation in screenings in Safranbolu district of Karabuk, Turkey in 2016-2017.
Methods: In this cross-sectional study, separate studying groups for cervix, breast and colorectal cancers were identified, taking into account the target age range specified in the national screening standards. The sample size was determined to be 374 for cervical cancer, 371 for breast cancer and 373 for colorectal cancer in the Epi-Info StatCalc program with a prevalence of 50%, a 95% Confidence Interval (CI) and a 5% error margin. The results of the data collected through face-to-face interview using questionnaires were evaluated with Chi-square tests (P<0.05) and included in the binary logistic regression model.
Results: Participation in PBS at least once between 2011 and 2016 years was 26.2% for cervical cancer, 27.6% for breast cancer and 31.6% for colorectal cancer, whereas the level of PBS or opportunistic screening at least once was 51.1%, 42.7% and 32.2%, respectively. A 2.9-fold increase in participation for the cervical cancer screening was associated with informing women about cervical cancer by the family physicians. Being married and living in the district center showed associations with a higher rate of participation for colorectal cancer screening.
Conclusion: Participation in PBS was low for the 5.5-year period. More effort is needed to increase the effectiveness of the program.
World Health Organization (2002). National cancer control programmes: policies and managerial guidelines. 2nd ed. World Health Organization Geneva.
Turkish Ministry of Health Refik Saydam Hygiene Center Presidency School of Public Health Directorate (2006). Turkey Burden of Disease Study 2004, Unuvar N, Mollahaliloğlu S, Yardım N, Eds. Ankara, Turkey.
Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11, International Agency for Research on Cancer, Lyon, France. Available from: http://globocan.iarc.fr/Default.aspx
Ministry of Health Turkey Public Health Institution Cancer Control Department (2016). Turkey Cancer Control Program. Ankara. Available from: https://www.iccp-portal.org/system/files/plans/Turkiye_Kanser_Kontrol_Program_English.pdf
McCoy CB, Pereyra M, Metsch LR et al (2004). A community-based breast cancer screening program for medically underserved women: Its effect on disease stage at diagnosis and on hazard of death. Rev Panam Salud Publica, 15 (3): 160-7.
Mandel JS, Bond JH, Church TR et al (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. The New England Journal of Medicine, 328:1365-71.
Denny L, Quinn M, Sankaranarayanan R (2006). Screening for cervical cancer in developing countries. Vaccine 24S3, S3/71-S3/77.
Landy R, Pesola F, Castañón A et al (2016). Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study. Br J Cancer, 115 (9): 1140-46.
Sherris J, Herdman C, Elias C (2001). Beyond our borders cervical cancer in the developing world. West J Med, 175:231-33.
Singh GK, Azuine RE, Siahpush M (2012). Global ınequalities in cervical cancer incidence and mortality are linked to deprivation, low socioeconomic status, and human development. International Journal of MCH and AIDS, 1 (1): 17-30.
European Commission (2017). Cancer Screening in the European Union (2017) Report on the implementation of the Council Recommendation on cancer screening. Available from: https://ec.europa.eu/health/sites/health/files/major_chronic_diseases/docs/2017_cancerscreening_2ndreportimplementation_en.pdf
Gakidou E, Nordhagen S, Obermeyer Z (2008). Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities. Plos Medicine, 5(6): 863-68.
Klabunde C, Blom J, Bulliard JL et al. (2015). Participation rates for organized colorectal cancer screening programmes: an international comparison. J Med Screen, 22: 119-126.
Döbrőssy L, Kovács A, Budai A (2015). Inequalities in cervical screening practices in Europe. Diversity and Equality in Health and Care, 12(2): 48-53.
Scepanovic M, Jovanovic O, Keber D et al. (2017). Faecal occult blood screening for colorectal cancer in Serbia: a pilot study. Eur J Cancer Prev, 26(3): 195-200.
Azeem K, Ševčíková J, Kyselý Z et al. (2016). Primary and secondary prevention of colorectal cancer in the Czech Republic. Prz Gastroenterol, 11: 1-5.
Roderick B, Miriam D, Albert CV (2006). Effectiveness of opportunistic screening for cancer of the cervix uteri. Malta Medical Journal, 18(3): 15-20.
Nieminen P, Kallio M, Anttila A et al. (1999). Hakama M. Organised versus spontaneous pap-smear screening for cervical cancer, a casecontrol study. Int J Cancer, 83:55-8.
Adab P, McGhee SM, Yanova J et al. (2004). Effectiveness and efficiency of opportunistic cervical cancer screening: comparison with organized screening. Med Care, 42(6): 600-9.
Kim JJ, Leung GM, Woo PP et al. (2004). Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong. J Public Health (Oxf), 26(2): 130-7.
Union for International Cancer Control (UICC) (2016). World Cancer Declaration Progress Report 2016, Graham K, Hakam Y, Kaza N, Mikhail M, Morton Doherty R, Tasker R, Torode J, Von der Muhll V eds. p.85. Available from: https://www.uicc.org/wcd-report
Triantafillidis JK, Vagianos C, Gikas A et al. (2017). Screening for colorectal cancer: the role of the primary care physician. European Journal Of Gastroenterology & Hepatology, 29:e1–e7.
Khalid-de Bakker C, Jonkers D, Smits K et al. (2011). Participation in colorectal cancer screening trials after first-time invitation: a systematic review. Endoscopy, 43: 1059-86.
Ozdemir R, Karacali M, Ozkan A et al. (2015). Family physicians’ roles in cancer care: a quantitatıve and qualitatıve study from Turkey. European Congress of Epidemiology 2015. Healthy Living ,Maastricht The Netherlands 25-27 June 2015 (abstract).
Skinner CS, Halm EA, Bishop WP et al. (2015). Impact of risk assessment and tailored versus nontailored risk information on colorectal cancer testing in primary care: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev, 24: 1523-30.
Sung JJ, Choi SY, Chan FK et al. (2008). Obstacles to colorectal cancer screening in Chinese: a study based on the health belief model. Am J Gastroenterol, 103: 974-81.
Anttila A, Lo¨nnberg S, Ponti A et al. (2015). Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries. European Journal of Cancer, 51(2): 241-51.
Hurtado JL, Bacigalupe A, Calvo M et al. (2015). Social inequalities in a population based colorectal cancer screening programme in the Basque Country. BMC Public Health, 15: 1021.
Fukuda Y, Nakamura K, Takano T et al. (2007). Socioeconomic status and cancer screening in Japanese males: Large inequlaity in middle-aged and urban residents. Environ Health Prev Med, 12(2): 90-6.
|Issue||Vol 49 No 4 (2020)|
|Population-based cancer screening Cervix; Breast; Colorectal; Turkey|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|